Arati Inamdar
Edison, NJ (USA)
Role(s):
Founder/Owner/Principal
Ansicht Scidel Inc.
Find More Startups
Startup
Location:
Edison
Industry:
Pharmaceuticals
Year Founded:
2015
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
"S" Corporation
Description:
We have developed a working therapy for rapidly metastatic brain tumors (glioblastoma). We have conducted pre-clinical studies and the data has shown success. There is no other successful therapy currently for glioblastoma. This is the only therapy. In addition, we have a Chimeric Antigen Receptor Therapy that is ready to undergo clinical development. We have reached these milestones with the help of development in facilities in China and India and we want to bring the technology to USA where the major market is available. We want to convert the S-corp to C-Corp and have an IPO to raise the capital and develop and market the product worldwide. The product is eligible for fast-track approval and only awaits the capital for further progress.